Stroke Cases More Than Double in Odisha in Two Years, Raising Health Concerns

Stroke Cases More Than Double in Odisha in Two Years, Raising Health Concerns

Bhubaneswar, Oct 29: Odisha is witnessing a sharp rise in stroke cases, with the number reported annually more than doubling in two years, according to state government data. The increase has raised concerns among medical professionals over the growing burden of stroke and the need for early diagnosis, timely treatment and stronger public awareness.

Stroke Cases More Than Double in Odisha in Two Years, Raising Health Concerns

The issue has gained significance on World Stroke Day, observed on October 29, as doctors stress the importance of recognising warning signs and seeking emergency medical care without delay.

Odisha recorded 4,252 stroke cases in 2023–24, while the number crossed 9,000 in 2025–26, official figures indicate. Doctors attribute the growing burden to a combination of health conditions and lifestyle-related factors, including hypertension, diabetes, obesity, smoking, unhealthy diets and physical inactivity. Genetic predisposition may also contribute to an individual’s risk.

Every Minute Matters in Stroke Treatment

Neurologists warn that the first four-and-a-half hours after the onset of stroke symptoms can be crucial for eligible patients. Timely medical assessment and appropriate treatment during this period can improve recovery prospects and reduce the risk of lasting disability.

Professor Dr Lulup Kumar Sahu emphasised the importance of acting quickly when stroke symptoms appear, urging people not to ignore warning signs or delay reaching a hospital.

Common symptoms include sudden facial drooping, weakness in an arm, difficulty speaking and paralysis or weakness affecting one side of the body. Sudden vision problems, loss of balance and severe unexplained headaches may also signal a medical emergency.

Doctors advise immediate hospital evaluation if any of these symptoms develop. The four-and-a-half-hour period is not a reason to wait, as treatment options depend on the patient’s condition, the type of stroke and how quickly medical care is received.

Stroke Cases More Than Double in Odisha in Two Years, Raising Health Concerns

 Representational Image 

SCB Medical College, AIIMS Bhubaneswar Report Rising Cases

The increasing number of patients is also being reflected at major healthcare institutions in the state.

The Neurology Department at SCB Medical College and Hospital in Cuttack treats around 400 stroke patients annually, with doctors reporting an upward trend. AIIMS Bhubaneswar has observed a similar pattern, according to the report.

Medical experts say the trend highlights the need to strengthen stroke awareness, improve access to specialised neurological care and encourage people to manage underlying health conditions before complications arise.

Understanding the Two Types of Stroke

Stroke generally occurs in two main forms, both of which can cause serious damage to the brain.

Ischaemic stroke: Occurs when a blood clot blocks a blood vessel supplying blood to the brain, depriving brain tissue of oxygen.

Haemorrhagic stroke: Occurs when a blood vessel in the brain ruptures, leading to bleeding that damages surrounding tissue.

Distinguishing between the two is essential because their treatments differ. Medical professionals must assess the patient and determine the appropriate course of action before treatment begins.

Senior Neurology Consultant Dr Laxmidhar Padhi has highlighted the importance of receiving medical attention within the critical early window, when eligible patients may benefit from time-sensitive interventions.

Rural Communities Face Significant Stroke Risk

The burden of stroke is also a concern in rural Odisha, where access to specialised healthcare can be challenging.

A study published in The Lancet Regional Health – Southeast Asia under the Indian Council of Medical Research’s National Stroke Registry Programme highlighted the risk faced by rural communities. According to the findings cited in the report, one in every seven people in rural Cuttack faces a lifetime risk of stroke.

The research examined stroke incidence and mortality across five regions of India during 2018–19. SCB Neurology Professor Dr Ashok Kumar Mallik was among the study’s co-authors.

The findings underline the importance of early symptom recognition, accessible emergency services and better management of risk factors, particularly in areas where reaching a specialised hospital may take considerable time.

Prevention and Awareness Remain Key

Doctors recommend regular monitoring of blood pressure and blood sugar, maintaining a healthy weight, following a balanced diet, avoiding tobacco and engaging in regular physical activity to reduce stroke risk.

For people with hypertension, diabetes or other underlying conditions, regular medical consultations and adherence to prescribed treatment are particularly important.

As Odisha’s reported stroke numbers continue to rise, health experts are calling for greater public awareness and improved access to timely care. Their central message on World Stroke Day is clear: recognising symptoms early and reaching a hospital immediately can make a critical difference to survival and long-term recovery.

Total Investment of Approx. USD 6.8 Million in Product Development for Malaria, NTDs and Other Emerging & Re-emerging Infectious Diseases Such as Ebola Disease

TOKYO, Oct. 29, 2026 /PRNewswire/ — The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.06 billion (USD 6.8 million1) in nine R&D projects for the development of drugs, vaccines and diagnostics for malaria, neglected tropical diseases (NTDs) and emerging & re-emerging infectious diseases such as Ebola disease. 2

Investment of approx. JPY 450 million (USD 2.9 million1) for Clinical Validation, Regulatory Approval and Programmatic Launch of Rapid Diagnostic Test for Trachoma

Trachoma is an NTD caused by infection with the bacterium Chlamydia trachomatis. It remains a public health problem and is responsible for causing blindness or visual impairment in approximately 1.9 million people globally. Currently, nearly 92 million people live in endemic areas and remain at risk of blindness due to trachoma3.

Trachoma control programs currently rely on Mass Drug Administration (MDA) of antibiotics. This creates a critical demand for a point-of-care rapid diagnostic test (RDT) to guide timely and accurate field-level decision-making on when to start or stop MDA.

The GHIT Fund has decided to invest approximately 450 million yen in a project to develop a rapid diagnostic test for trachoma, led by Drugs and Diagnostics for Tropical Diseases (DDTD), Medical & Biological Laboratories Co., Ltd. (MBL), The Carter Center, and Big Eye Diagnostics, Inc. Supported by the GHIT Fund since 2024, the project aims to establish a diagnostic test that fully complies with the WHO Target Product Profile (TPP). This new investment will further accelerate clinical evaluations, regulatory approvals, and programmatic launch.

The GHIT Fund Invests Approximately JPY 210 Million (USD 1.3 million1) to Meet Urgent Need for Rapid Diagnostic Development for Ebola Disease

Ever since the World Health Organization (WHO) declared a Public Health Emergency of International Concern (PHEIC) on May 17, 2026 (Japan time) in response to the outbreak of Ebola disease caused by the Bundibugyo virus in the Democratic Republic of the Congo (DRC) and Uganda, the GHIT Fund has focused its support on product development for rapid diagnostic technologies and point-of-care (POC) testing for filovirus infections, including Ebola disease.

An outbreak with over 4,500 deaths as of October 21, 2026, has been reported in the DRC4. Rapid diagnosis is essential to prevent transmission, and the GHIT Fund has decided to invest a total of approximately JPY 210 million (USD 1.3 million1) in three projects for the rapid diagnosis of Ebola disease. For details, please refer to Appendix 1.

1) Development of a new RT-LAMP/nucleic acid chromatography diagnostic device for rapid screening of for the Bundibugyo virus led by Medical & Biological Laboratories Co., Ltd. and Nagasaki University in Japan.

2) Development and field investigation of a lateral flow immunoassay for the Ebola hemorrhagic fever Bundibugyo strain in the DRC led by Saitama University in Japan.

3) Development of a LAMP-based assay for detection of Bundibugyo virus (BDBV) led by Eiken Chemical Co. Ltd. in Japan.

In addition, the GHIT Fund will invest a total of approximately JPY 400 million (approx. USD 2.5 million1) in the following five R&D projects. These include a project to develop a next-generation vaccine against Lassa fever, which is widespread in West Africa, as well as rapid antigen tests (RAT) for high-priority zoonotic pathogens, specifically the Nipah and Hendra viruses, which pose a risk of severe outbreaks with potential “Disease X” pandemic capacity. Investment will also cover product development for malaria and neglected tropical diseases (NTDs), such as dengue fever, chikungunya, and Chagas disease.

  1. Construct and formulation optimization and efficacy evaluation of a bivalent mRNA-lipid nanoparticle vaccine for Lassa virus led by the University of Osaka (Center for Advanced Modalities and Drug Delivery System [CAMaD], Research Institute for Microbial Diseases [RIMD], and Graduate School of Medicine [UOsaka Med]) and The University of Texas Medical Branch (UTMB).



  2. Strategic high-performance immunoglobulins for epidemic and lethal diseases, and to develop a highly accurate rapid antigen test (RAT) for detecting Nipah virus (NiV) and Hendra virus (HeV) infections, both of which have the potential to cause severe outbreaks, led by PATH and iBody Inc.



  3. Improving antimalarial potency of antisense oligonucleotides through bioinformatics and machine-learning algorithms led by Eisai Co., Ltd. and Medicines for Malaria Venture (MMV).



  4. Innovative approaches to improve success rate in Chagas disease drug discovery led by Nagasaki University, Eisai Co., Ltd., Drugs for Neglected Diseases initiative and University of Dundee.



  5. Rapid whole-blood multiplex antigen test for serotype-specific dengue and chikungunya detection led by VisGene, Ltd., University of Miyazaki, Mahidol University, Universidad Nacional Mayor de San Marcos in Peru and Centro de Investigaciones Tecnologicas, Biomedicas y Medioambientales in Peru.

Please refer to Appendix 1 for detailed descriptions of these projects and their development stages.

As of September 30, 2026, there are 53 ongoing projects, including 26 discovery projects, 14 preclinical projects, and 13 clinical trials5 in the GHIT Fund’s portfolio. The total amount of investments since 2013 is JPY 48.1 billion (USD 305 million1) (Appendix 2).

1 USD 1 = JPY 157.31, the approximate exchange rate on Sep 30, 2026.

2 These awarded projects were selected and approved as new investments from among proposals to RFP2025-002 and RFP2026-001 for the Target Research Platform, the Screening Platform, the Hit-to-Lead Platform, and the Product Development Platform.

3 WHO: https://www.who.int/news-room/fact-sheets/detail/trachoma

4
Centers for Disease Control and Prevention https://www.cdc.gov/ebola/situation-summary/index.html

5
This number includes projects in the registration phase.

The GHIT Fund is a Japan-based international public-private partnership (PPP) fund that was formed between the Government of Japan, multiple pharmaceutical companies, the Gates Foundation, Wellcome, and the United Nations Development Programme (UNDP). The GHIT Fund invests in and manages an R&D portfolio of development partnerships aimed at addressing neglected diseases, such as malaria, tuberculosis, and neglected tropical diseases, which afflict the world’s vulnerable and underserved populations. In collaboration with global partners, the GHIT Fund mobilizes Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics for malaria, tuberculosis, and neglected tropical diseases. https://www.ghitfund.org/

Appendix 1. Project Details

ID: G2026-104

Project Title

Progressing a Fully TPP-Compliant, Field-Validated, and Manufacturable Trachoma RDT to Regulatory Approval and Programmatic Launch.

Collaboration

Partners

1. Drugs & Diagnostics for Tropical Diseases (USA)

2. Medical & Biological Laboratories Co., Ltd. (Japan)

3. The Carter Center (USA)

4. Big Eye Diagnostics, Inc. (BEDx/USA)

Disease

Trachoma

Intervention

Diagnostics

Stage

Clinical Validation, Registration

Awarded Amount

JPY 456,338,720 (USD 2.9 million)

Status

Continued project

Summary

[Project objective]

The primary objective is to bring the new trachoma dipstick rapid test from an advanced, manufacturable candidate to regulatory acceptance and programmatic launch in 2028. The test is designed for high-throughput laboratory testing of dried blood spots and serum and has already demonstrated the performance, usability, heat stability, and affordability expected by trachoma programs. During this project, the consortium will establish a verification and validation (V&V) plan in consultation with relevant WHO and technical experts, conduct the required V&V studies both in the laboratory and in the field using production-quality pilot lots, compile a complete regulatory dossier, and support a launch decision by global trachoma stakeholders. A second objective is conditional on programmatic demand: the consortium is also evaluating a cassette version that uses the same assay strip but adds a blood filter, enabling testing with fingerstick blood at or near the point of care. Evidence on performance, cost, operational feasibility, and user and community acceptance will guide whether this format should also proceed through verification, validation, regulatory review, and launch. A third, objective is to advance pre-conjugated, freeze-dried Pgp3 multiplex bead assay (MBA) beads which have been shown in the precursor project, G2024-108, to maintain the same diagnostic performance as freshly prepared beads – yet with proven thermal stability for at least two weeks at room temperature. This project will optimize and scale the process, assess reproducibility and thermal stability, obtain independent laboratory validation, and produce pilot lots. Together, these objectives aim to provide trachoma programs with practical diagnostic options spanning centralized laboratories, field settings, and integrated multiplex surveillance. Finally, this project will also continue manufacturing the new Pgp3 dipstick to cover immediate and pressing programmatic needs while waiting for regulatory approval to be secured.

[Project design]

The project is organized as a staged development program with clear decision points. First, the consortium will prepare a detailed verification and validation plan for the dipstick test in consultation with relevant WHO scientific and diagnostic experts. The plan will define the laboratory studies and, if required, field studies needed to demonstrate that independently manufactured lots perform consistently under realistic operating, transport, storage, and use conditions. A separate plan will be prepared for the cassette version only if trachoma programs decide that this format is needed. Second, Medical & Biological Laboratories will supply production-grade Pgp3 antigens, while Big Eye Diagnostics will manufacture tests under an ISO-13485:2016 certified quality system to cover immediate and urgent programmatic needs. The three pilot lots will undergo laboratory verification studies covering performance, repeatability, reproducibility, specimen-related variables, stability, and other parameters. The Carter Center will coordinate any additional field validation studies required by, and included in the V&V plan, in trachoma-endemic countries. Results will be reviewed with stakeholders and incorporated into the manufacturer’s quality records. Once all results from the V&V studies are available, the consortium will assemble and submit the regulatory dossier to the appropriate WHO-supported review mechanism, respond to questions, and work with stakeholders on programmatic introduction. The multiplex bead work follows its own go/no-go pathway, whereby the team will optimize conjugation and freeze-drying, demonstrate scale-up and inter-laboratory reproducibility, assess thermal stability, obtain independent validation, and manufacture three pilot lots to lay the ground for future development.

Project Detail

https://www.ghitfund.org/investment/portfoliodetail/detail/281/en

ID: G2026-124

Project Title

Development of a new RT-LAMP / nucleic acid chromatography diagnostic device for the rapid screening of Bundibugyo virus

Collaboration

Partners

1. Medical & Biological Laboratories Co., Ltd. (Japan)

2. Nagasaki University (Japan)

Disease

Ebola Disease

Intervention

Diagnostics

Stage

Product design

Awarded Amount

JPY 171,000,000 (USD 1.1 million)

Status

New project

Summary

[Project objective]

The objective of this project is to develop a novel diagnostic device for the rapid and, user-friendly detection of Bundibugyo ebolavirus. Given the limited availability of laboratory infrastructure and trained healthcare personnel in outbreak-affected regions, the project aims to establish a diagnostic system that can be used in field settings, including healthcare facilities and community clinics, without requiring sophisticated laboratory equipment. By enabling early identification of infected individuals and timely implementation of infection control measures, the proposed system is expected to contribute to reducing disease transmission and supporting outbreak containment.

[Project design]

This project aims to develop a novel diagnostic method that combines RT-LAMP with nucleic acid chromatography to enable rapid and accessible visual detection of Bundibugyo ebolavirus. Unlike conventional PCR-based methods, MEBLINE BDBV does not require the sophisticated laboratory equipment used for PCR testing, making it suitable for use in healthcare facilities and community clinics. By combining the accuracy of molecular diagnostic tests with the rapid and practical features of antigen tests, this technology can support the rapid detection of infected individuals in outbreak settings.

Furthermore, the platform may be adaptable to the detection of other Ebola virus species, providing a valuable tool for preparedness against future outbreaks.

Project Detail

https://www.ghitfund.org/investment/portfoliodetail/detail/282/en

ID: T2026-193

Project Title

Development and field investigation of a lateral flow immunoassay for the Ebola hemorrhagic fever Bundibugyo strain in the Republic of Congo

Collaboration

Partners

1. Saitama University (Japan)

Disease

Ebola Disease

Intervention

Diagnostics

Stage

Technical Feasibility

Awarded Amount

JPY 20,000,000 (USD 0.1 million)

Status

New project

Summary

[Project objective]

The objective of this project is to develop a portable diagnostic kit capable of detecting Ebola virus infection with high sensitivity in less than 15 minutes. The test will be designed for use by frontline healthcare workers without requiring laboratory infrastructure, enabling earlier detection, patient isolation, and treatment. Ultimately, the project aims to support global Ebola control efforts and contribute to improved public health outcomes through faster and more accessible diagnosis.

[Project design]

The project will first identify Ebola-specific target antigens and high-performance antibody pairs. These components will then be integrated into a highly sensitive diagnostic platform based on proprietary Aggregation-Induced Emission (AIE) fluorescent nanoparticle technology. The prototype will be optimized for analytical performance and evaluated for stability under harsh environmental conditions, such as high temperature and humidity. Usability testing will also be conducted to ensure effective operation in resource-limited settings. In parallel, preparations will be made for future clinical validation and regulatory approval.

Project Detail

https://www.ghitfund.org/investment/portfoliodetail/detail/283/en

ID: T2026-194

Project Title

Development of a LAMP-based assay for detection of Bundibugyo virus

Collaboration

Partners

1. Eiken Chemical Co. Ltd. (Japan)

Disease

Ebola Disease

Intervention

Diagnostics

Stage

Technical Feasibility

Awarded Amount

JPY 19,506,586 (USD 0.1 million)

Status

New project

Summary

[Project objective]

The project aims to develop a prototype reverse-transcription LAMP reagent that can detect Bundibugyo (BDBV) rapidly and specifically. The target is to achieve a 15-minute result while maintaining sensitivity comparable to existing real-time PCR assays. The project will also evaluate whether the assay can be used with multiple real-time PCR instruments. Ultimately, the prototype developed through this project is intended to undergo external pre-evaluation by WHO or other public health organizations to demonstrate its potential utility for future clinical applications.

[Project design]

The six-month project consists of three sequential stages. First, Eiken will compare publicly available BDBV genome sequences, select conserved target regions, and design LAMP primers and fluorescence probes. Candidate assays will be screened using non-infectious synthetic RNA or equivalent reference materials, and reaction conditions will be optimized for rapid and specific detection. Second, the selected assay will undergo preliminary analytical evaluation, including sensitivity, interference, and instrument-compatibility studies using contrived whole-blood or plasma samples. Third, the optimized formulation will be transferred to a freeze-dried prototype format. Eiken will manufacture 10,000 prototype tests using existing facilities and conduct performance evaluation.

Project Detail

https://www.ghitfund.org/investment/portfoliodetail/detail/284/en

ID: T2025-257

Project Title

Construct and formulation optimization and efficacy evaluation of a bivalent mRNA-lipid nanoparticle vaccine for Lassa virus

Collaboration

Partners

1. The University of Osaka (Center for Advanced Modalities and Drug Delivery System, CAMaD) (Japan)

2. The University of Osaka (Research Institute for Microbial Diseases, RIMD) (Japan)

3. The University of Texas Medical Branch at Galveston (UTMB/USA)

4. The University of Osaka (Graduate School of Medicine, UOsaka Med) (Japan)

Disease

Lassa Fever

Intervention

Vaccines

Stage

Vaccine Design

Awarded Amount

JPY 100,000,000 (USD 0.6 million)

Status

New project

Summary

[Project objective]

The objective of this project is to advance a safe, effective, and field‑deployable bivalent mRNA-LNP vaccine against Lassa virus (LASV) by encoding both LASV GPC and NPL within a single bicistronic mRNA construct. This approach aims to enhance antigenic breadth, improve protective immunity, and streamline manufacturing for future deployment in resource‑limited settings. During the project period, we will evaluate vaccine efficacy and immunogenicity in multiple animal models, including a bona fide LASV infection model, and optimize LNP formulations for improved thermal stability. These efforts will accelerate the transition toward clinical development of a thermostable, accessible LASV mRNA vaccine.

[Project design]

We will develop and validate a bicistronic mRNA encoding LASV GPC and NP, supported by analytical assays to ensure its quality and manufacturability. Bicistronic mRNA-LNPs will be tested in the BSL-2 infection model to assess immunogenicity and protection, and promising candidates will be evaluated in a lethal guinea pig model of authentic LASV infection under BSL-4 conditions. Thermostable LNP formulations will be optimized through lyophilization and compositional adjustments, and their stability will be assessed at elevated temperatures. A scalable manufacturing process will be established to produce preclinical-grade vaccine lots using a controlled mixing method suitable for future clinical production. Finally, protective efficacy will be evaluated in a lethal BSL-4 guinea pig model to support the progression toward clinical development.

Project Detail

https://www.ghitfund.org/investment/portfoliodetail/detail/285/en

ID: T2026-152

Project Title

Strategic High-Performance Immunoglobulins for Epidemic and Lethal Diseases (SHIELD)

Collaboration

Partners

1. PATH (US)

2. iBody Inc. (Japan)

Disease

Nipah and Hendra virus Infection

Intervention

Diagnostics

Stage

Technical Feasibility

Awarded Amount

JPY 99,900,000 (USD 0.6 million)

Status

New project

Summary

[Project objective]

Our goal is to deliver an affordable, robust, easy-to-use, and highly accurate RAT that detects and discriminates between Nipah virus (NiV) and Hendra virus (HeV) infections. This tool will enable early outbreak detection in rural and LRSs, reducing transmission and saving lives.

[Project design]

The project combines the identification of appropriate immunogens, innovative antigen design, and memory B cell antibody screening with iBody’s Ecobody technology for very rapid, high-throughput identification of highly specific recombinant Fabs. These will be sequenced and used to develop recombinant forms of IgG that will be assessed by PATH for performance and suitability for use in immunoassays.

Project Detail

https://www.ghitfund.org/investment/portfoliodetail/detail/286/en

ID: S2025-211

Project Title

Improving antimalarial potency of antisense oligonucleotides through bioinformatics and machine-learning

Collaboration

Partners

1. Eisai Co., Ltd. (Japan)

2. Medicines for Malaria Venture (MMV/Switzerland)

Disease

Malaria

Intervention

Drug

Stage

Screening

Awarded Amount

JPY 24,031,200 (USD 0.1 million)

Status

New project

Summary

[Project objective]

The primary objective of this project is to use bioinformatic approaches and machine learning algorithms to further expand on our previous findings and identify ASOs against Plasmodial genes with improved potency and broader target coverage that are active across multiple parasite species.

[Project design]

In this project, we will design ASOs that target conserved regions of P. falciparum and P. berghei genes using bioinformatic approaches. These ASOs will be screened against P. falciparum blood-stages and against P. berghei liver-stages using standard assays. The results will be integrated in machine-learning algorithms to further optimize ASO design. We expect that this screening will identify ASOs with improved potency and broader target coverage, which can then be validated for on-target activity using existing genetic tools.

Project Detail

https://www.ghitfund.org/investment/portfoliodetail/detail/287/en

ID: T2025-261

Project Title

Innovative approaches to improve success-rate in Chagas disease drug discovery

Collaboration

Partners

1. Nagasaki University (Japan)

2. Eisai Co., Ltd. (Japan)

3. Drugs for Neglected Diseases initiative (Switzerland)

4. University of Dundee (UK)

Disease

Chagas disease

Intervention

Drug

Stage

Drug Discovery

Awarded Amount

JPY 99,910,714 (USD 0.6 million)

Status

New project

Summary

[Project objective]

The main objective of this project is to increase the success rate of Chagas disease drug discovery by identifying promising drug candidates more reliably at an earlier stage.

Specifically, the project aims to:

  1.  Develop and validate new laboratory tests that can detect whether a drug candidate has the potential to fully eliminate the parasite.
  2. Use these tests to identify new starting points for future drug development.
  3. Understand why certain drug candidate combinations are especially effective, to design safer and more effective treatments.

By achieving these goals, the project will help ensure that only the most promising compounds move forward in the drug development pipeline. This reduces the risk of late-stage failure and supports the development of treatments that are more likely to prove effective for patients.

[Project design]

The project is organized into three coordinated research components.

First, a high-throughput laboratory test is used to rapidly measure how quickly compounds kill the parasites that cause Chagas disease inside human cells. This allows thousands of compounds to be screened efficiently and identifies those with strong anti-parasitic activity.

Second, a complementary imaging-based test examines whether parasites return after treatment is stopped. This step is critical for identifying compounds that truly eliminate all parasites.

Third, the project investigates why certain drug combinations work better than single drugs. By understanding the biological mechanisms behind these effects, researchers can design more effective combination therapies.

Together, these steps form a screening ‘pipeline’ that moves from fast testing to deeper biological understanding, ensuring robust and reliable results.

Project Detail

https://www.ghitfund.org/investment/portfoliodetail/detail/288/en

ID: T2025-283

Project Title

Rapid Whole-Blood Multiplex Antigen Test for Serotype-Specific Dengue and Chikungunya Detection

Collaboration

Partners

1. VisGene, Ltd. (Japan)

2. University of Miyazaki (Japan)

3. Mahidol University (Thailand)

4. Universidad Nacional Mayor de San Marcos (UNMSM/Peru)

5. Centro de Investigaciones Tecnologicas, Biomedicas y Medioambientales (CITBM /Peru)

Disease

Dengue, Chikungunya

Intervention

Diagnostics

Stage

Technical Feasibility

Awarded Amount

JPY 77,790,558 (USD 0.4 million)

Status

New project

Summary

[Project objective]

The objective of this project is to develop and validate a rapid antigen test capable of simultaneously detecting and differentiating dengue virus serotypes 1–4 and chikungunya virus directly from whole blood within 15 minutes. Differences among dengue virus serotypes are known to influence clinical outcomes and the risk of severe disease. This test is intended to support early diagnosis, appropriate patient management, and effective outbreak response.

[Project design]

The project integrates serotype-specific detection technology targeting the dengue virus NS1 antigen with monoclonal antibodies against the chikungunya virus E1 antigen into a rapid immunochromatographic device. Clinical evaluations will be conducted in Thailand and Peru, followed by regulatory submissions and development activities with the aim of supporting future regulatory approval and potential WHO prequalification.

Project Detail

https://www.ghitfund.org/investment/portfoliodetail/detail/289/en

*All amounts are listed at an exchange rate of USD 1 = JPY 157.31, the approximate exchange rate on September 30, 2026.

Appendix 2. Investment Overview (as of September 30, 2026)

Investments to date

Total investments: JPY 48.1 billion (USD 305 million1)

Total invested projects: 158 (53 active projects and 105 completed projects)

To learn more about the GHIT Fund’s investments, please visit

Investment Overview: https://www.ghitfund.org/investment/overview/en

Portfolio: https://www.ghitfund.org/investment/portfolio/en

Advancing Portfolio: https://www.ghitfund.org/investment/advancingportfolio/en

Clinical Candidates: https://www.ghitfund.org/investment/clinicalcandidates/en

For more information, contact:

Katy Lenard at +1-202-494-2584 or klenard@burness.com

Eriko Mugitani at +81-36441-2032 or eriko.mugitani@ghitfund.org

Cision View original content:https://www.prnewswire.co.uk/news-releases/total-investment-of-approx-usd-6-8-million-in-product-development-for-malaria-ntds-and-other-emerging–re-emerging-infectious-diseases-such-as-ebola-disease-302922667.html

Total Investment of Approx. USD 6.8 Million in Product Development for Malaria, NTDs and Other Emerging & Re-emerging Infectious Diseases Such as Ebola Disease

Odisha Government Approves Rs 47.35 Crore for Widening and Strengthening of Goudaguda–Sarangpali Road to Boost Connectivity in Malkangiri District

Malkangiri,Oct 29 [UDN}:   In a significant step towards improving road infrastructure in Malkangiri district of Odisha, the Public Works Department (PWD) has granted administrative approval for the widening and strengthening of the Goudaguda–Sarangpali road at an estimated cost of ₹47 crore, 35 lakh and 36 thousand (₹47.3536 crore).

The project aims to strengthen the district’s road connectivity and improve transportation facilities for residents in the region. Once implemented, the road improvement work is expected to facilitate smoother movement, enhance accessibility and support the overall socio-economic development of the surrounding areas.

The project marks an important step towards strengthening rural infrastructure in Malkangiri district and providing improved road connectivity, which can contribute to regional growth and development.

Investor Meetings Are Returning. Indian Companies Need a New Roadshow Playbook for Dubai: Gulamaly Hussain

The article examines why Indian companies are rediscovering face-to-face investor engagement—and why the answer is not more travel or meeting-count roadshows, but more deliberate access at the moments when trust, judgement and accountability matter.

For several years, investor relations became exceptionally efficient. A management team could meet institutions across three continents in a week without leaving its office. Quarterly updates moved online, attendance widened and the cost of access fell sharply. Few companies would willingly give up those gains.

Yet the market is quietly moving back into the room. Irwin’s 2026 State of Investor Relations research, based on responses from more than 200 professionals across the investor-relations ecosystem, found that 52% of IR teams were increasing in-person engagement. The same research found that 60% planned to host live investor or analyst events. This is not nostalgia for the pre-pandemic roadshow. It is a practical response to a problem that technology has not solved: information can travel digitally, but conviction often develops more slowly.

For Indian companies raising capital and engaging investors in Dubai and other financial centres, this is a practical question of public-market communication. Investors have more information than ever, including automated summaries, social-media commentary and AI-assisted analysis. Access to information is no longer the constraint. The harder task is deciding what deserves belief.

A virtual meeting is perfectly suited to a routine update, a first introduction or a follow-up on a known issue. It is less reliable when the investment case depends on how management handles ambiguity. A screen gives investors the prepared answer. A room often reveals the quality of the thinking behind it: whether the chief executive and chief financial officer interpret the risk in the same way, whether a difficult question is considered or deflected, and whether management can acknowledge what it does not yet know.

This should not be reduced to body language. Investors are not trying to conduct amateur psychology. They are assessing judgement. When a company is changing leadership, entering a new market, raising capital, making a large acquisition or recovering from a setback, the decision rests on more than the slide deck. Investors want to understand how the leadership team reaches decisions, how it treats dissent and what it will do if the assumptions change.

The wrong conclusion would be to bring back the exhausting calendar of back-to-back meetings and measure success by the number of handshakes. A full roadshow can still be a poor roadshow. Senior management time is scarce, and not every investor requires the same degree of access. The better approach is selective: use digital formats for reach and continuity, and reserve the room for moments when a relationship, a strategic shift or a difficult judgement genuinely needs depth.

This is especially important in cross-border fundraising between India, Dubai and the wider Gulf markets. A company may have a persuasive growth story, but investors in Dubai and other GCC markets also evaluate governance, reporting discipline, the reliability of forecasts, local relationships and the route to returns. Those questions rarely fit neatly into a single fundraising call. The strongest conversations begin before capital becomes urgent. By the time a company needs the cheque, the investor should already understand how management communicates when there is no transaction to sell.

In practice, this changes how an IR team prepares. The first question is no longer, ‘How many meetings can we fit into a Dubai trip?’ It is, ‘What must be different after this meeting?’ For one investor, the purpose may be to resolve a concern about capital allocation. For another, it may be to introduce a new leader. For a third, it may simply be to listen and understand why the company has remained outside the portfolio.

Good preparation also means giving management enough context to have a real conversation. A useful brief does not merely reproduce the investor’s public profile. It explains the investor’s likely thesis, current exposure, earlier questions and possible points of disagreement. Management should know which answer belongs to whom, where the evidence sits and which questions cannot responsibly be answered. A candid ‘we are still assessing that’ is often more credible than an elaborate answer designed to fill the silence.

Technology still has a valuable role. The same 2026 research found that AI adoption by IR teams had risen from 6% to 42% in a year. Used well, it can prepare meeting briefs, compare transcripts, identify recurring questions and make follow-up more disciplined. It can reduce the administrative load around a meeting. It cannot take responsibility for the judgement expressed in it.

Companies also need better measures of whether in-person investor meetings are building understanding and trust. Meeting count is an activity metric, not an outcome. More useful signals include whether questions became more specific, whether an investor requested a second conversation, whether a previously misunderstood part of the strategy became clearer, and whether feedback reached the board and influenced disclosure. Some priority investors will take several quarters, or longer, to develop conviction. A meeting should not be declared unsuccessful because it did not produce an immediate change in the share register.

The future of investor relations is therefore neither physical nor virtual. It is deliberately hybrid. Virtual access keeps the conversation alive and broadens the field. In-person access is used where trust, nuance and accountability carry a premium. The companies that understand the difference will travel less indiscriminately, prepare more intelligently and get more value from the time they do spend in the room.

 About Gulamaly Hussain

Gulamaly Hussain is a Dubai-based senior banker and investor relations professional with experience across private equity, banking, capital markets, fundraising and GCC investor coverage. His work spans capital raising, investor confidence, due diligence and cross-border capital communication.

With an understanding of Dubai’s role as a regional financial and investment centre and the expectations of institutional investors across the GCC, he focuses on fundraising readiness, investor communication, governance, private capital and India–GCC investment opportunities.

HR Strategies for Employee Engagement: Building a Motivated, Productive and Loyal Workforce

HR Strategies for Employee Engagement: Building a Motivated, Productive and Loyal Workforce

 

Introduction

Employee engagement has become a strategic priority for organisations seeking sustainable growth, improved productivity and long-term business success. In an increasingly competitive business environment, companies can no longer rely solely on salaries, incentives and traditional management practices to retain talented employees. They must create a workplace where people feel valued, motivated, supported and connected to organisational goals.

Human Resources (HR) plays a crucial role in developing and implementing strategies that improve employee engagement. From transparent communication and career development to employee recognition, workplace flexibility and leadership support, effective HR practices can significantly influence how employees perceive their work and contribute to business objectives.

Employee engagement goes beyond job satisfaction. While a satisfied employee may be comfortable with their role, an engaged employee demonstrates commitment, takes initiative, collaborates with colleagues and actively contributes to organisational success.

For businesses of all sizes, developing a comprehensive employee engagement strategy is essential to building a resilient, innovative and high-performing workforce.

1. Establish Clear Communication Channels

Effective communication is the foundation of employee engagement. Employees are more likely to feel connected to their organisation when they understand its objectives, priorities, challenges and expectations.

HR departments should establish communication channels that encourage transparency and enable employees to share their ideas, concerns and feedback without hesitation.

Regular team meetings, leadership town halls, internal newsletters, employee portals and one-to-one discussions can help maintain a consistent flow of information. Managers should communicate organisational changes clearly and explain how these changes may affect individual roles and responsibilities.

Two-way communication is particularly important. Employees should have opportunities to ask questions, express concerns and contribute suggestions. HR teams can introduce anonymous feedback mechanisms, employee surveys and open-door policies to encourage participation.

When employees believe their opinions matter, they are more likely to develop trust in management and feel a stronger sense of belonging.

2. Recognise and Reward Employee Contributions

Recognition is a powerful tool for strengthening employee engagement. Employees who believe their efforts are appreciated are more likely to remain motivated and committed to their responsibilities.

HR teams should develop structured recognition programmes that acknowledge achievements, teamwork, innovation, customer service and consistent performance.

Recognition does not always need to involve financial rewards. Public appreciation during team meetings, personalised thank-you messages, certificates, additional learning opportunities and flexible benefits can also make employees feel valued.

However, recognition programmes should be transparent and fair. Organisations must ensure that rewards are based on clear criteria rather than personal relationships or managerial preferences.

A balanced approach can combine monetary incentives, performance bonuses, promotions and non-financial recognition. Managers should also encourage peer-to-peer recognition, allowing colleagues to appreciate one another’s contributions.

By creating a culture of appreciation, organisations can reinforce positive behaviour and improve workplace morale.

3. Invest in Employee Training and Career Development

Career development is a major factor influencing employee motivation and retention. Employees want to know that their organisation is interested in their professional growth and future opportunities.

HR departments should identify skill gaps, assess employee aspirations and design learning programmes that support both individual development and business requirements.

Training initiatives may include technical workshops, leadership development, mentoring, cross-functional assignments, professional certifications and online learning programmes.

Individual development plans can help employees understand the skills they need to progress within the organisation. Regular career discussions also enable managers to identify high-potential employees and prepare them for future responsibilities.

Internal mobility should be encouraged wherever possible. Promoting qualified employees into new roles or offering opportunities to work across departments can improve retention while reducing recruitment costs.

In a rapidly changing business environment, continuous learning is particularly important. Organisations that invest in employee development are better positioned to adapt to new technologies, evolving customer expectations and changing market conditions.

4. Promote Work-Life Balance and Workplace Flexibility

Work-life balance has become an important consideration for employees across industries. Excessive workloads, inflexible schedules and prolonged workplace stress can reduce engagement and increase the risk of burnout.

HR teams should develop policies that support employees in managing professional responsibilities alongside personal commitments.

Depending on operational requirements, organisations can consider flexible working hours, hybrid work arrangements, remote work options, compressed workweeks and improved leave policies.

Managers should focus on outcomes and performance rather than measuring commitment solely through the number of hours employees spend at their desks.

Clear workload allocation is equally important. HR teams should regularly review staffing levels, deadlines and work distribution to identify potential pressure points.

Organisations should also discourage unnecessary after-hours communication and promote reasonable boundaries between work and personal life.

Workplace flexibility must be implemented fairly, with clear eligibility criteria and measurable expectations. When employees feel trusted to manage their responsibilities, they are more likely to demonstrate accountability and commitment.

5. Build a Positive and Inclusive Workplace Culture

Workplace culture influences how employees interact with colleagues, respond to challenges and perceive their organisation. A positive culture encourages collaboration, mutual respect, accountability and shared purpose.

HR departments should define organisational values and ensure that they are reflected in everyday workplace practices. Diversity, equity and inclusion should be integrated into recruitment, promotion, performance management and leadership development.

Employees should have equal opportunities to contribute, regardless of their background, role or level of seniority. Discrimination, harassment, bullying and unfair treatment must be addressed through clear policies and appropriate reporting mechanisms.

HR teams should also encourage collaboration between departments through cross-functional projects, team-building activities and knowledge-sharing sessions.

Social events can strengthen workplace relationships, but they should not replace meaningful improvements in management practices, workload distribution or employee well-being.

A healthy organisational culture is created when leadership behaviour consistently reflects the values the company promotes.

6. Strengthen Leadership and Managerial Effectiveness

Managers have a direct influence on employee engagement because they shape employees’ day-to-day working experiences. Even well-designed HR policies may fail if managers do not implement them effectively.

Organisations should invest in leadership development programmes that help managers communicate clearly, provide constructive feedback, resolve conflicts and support employee growth.

Managers should be trained to recognise signs of disengagement, such as declining participation, reduced collaboration, persistent frustration or changes in performance.

Regular one-to-one meetings can help employees discuss challenges, clarify expectations and identify opportunities for improvement. These conversations should focus not only on performance but also on workload, career aspirations and workplace support.

HR teams should also hold managers accountable for their contribution to employee engagement. Leadership assessments can include indicators such as team retention, employee feedback, development progress and the quality of performance discussions.

A supportive manager can help employees feel confident, respected and motivated, while poor management can undermine trust even in an otherwise attractive workplace.

7. Use Employee Feedback to Drive Continuous Improvement

Employee engagement strategies are most effective when they respond to employees’ actual experiences rather than management assumptions.

HR departments should regularly collect feedback through pulse surveys, annual engagement surveys, focus groups, exit interviews and confidential conversations.

Surveys may assess leadership trust, job satisfaction, workload, recognition, career opportunities, team relationships and confidence in organisational communication.

However, collecting feedback is only the first step. HR teams must analyse the findings, identify recurring issues and communicate the actions the organisation intends to take.

For example, if employees report limited career progression, HR may introduce internal job postings, structured career discussions and mentoring programmes. If workload concerns are widespread, management may need to review staffing requirements and operational processes.

Employees should receive updates on the progress of these initiatives. When organisations request feedback but fail to respond, employees may become less willing to participate in future surveys.

A continuous feedback cycle helps HR teams identify emerging concerns and make evidence-based improvements.

8. Prioritise Employee Well-Being and Mental Health

Employee well-being is closely connected to workplace performance, attendance and retention. Organisations that overlook employee health and stress levels may face higher absenteeism, reduced productivity and increased turnover.

HR departments should adopt a comprehensive approach to physical, mental and emotional well-being.

Possible initiatives include employee assistance programmes, access to counselling resources, wellness workshops, stress-management training, health awareness campaigns and appropriate medical benefits.

Managers should be encouraged to discuss workloads and workplace pressures without stigmatising employees who need support.

Organisations must also address the underlying causes of workplace stress. Wellness programmes cannot compensate for unreasonable deadlines, persistent understaffing, unclear responsibilities or unsupportive management.

Employee well-being should therefore be incorporated into workforce planning, leadership practices and organisational policies.

When employees feel that their health and personal needs are respected, they are more likely to trust their employer and maintain sustainable performance.

9. Align Individual Roles With Organisational Goals

Employees are more likely to remain engaged when they understand how their work contributes to the organisation’s wider mission.

HR teams should work with business leaders to translate corporate objectives into clear departmental targets and individual performance expectations.

Employees should understand not only what they are expected to accomplish but also why their contributions matter.

For example, a customer service employee should understand how their work influences customer satisfaction and retention. Similarly, a production employee should recognise how quality control affects operational efficiency and brand reputation.

Goal-setting frameworks such as Objectives and Key Results (OKRs) or clearly defined Key Performance Indicators (KPIs) can help organisations connect individual responsibilities with business priorities.

These frameworks should be supported by regular progress discussions, realistic targets and access to the resources employees need to succeed.

A strong sense of purpose can encourage employees to take ownership of their work, contribute new ideas and collaborate more effectively with colleagues.

10. Leverage Technology to Improve Employee Engagement

Digital HR tools can help organisations improve communication, simplify administrative processes and gain better insights into employee experiences.

Employee self-service portals, learning management systems, performance management platforms, digital recognition tools and engagement survey software can make HR services more accessible.

Artificial intelligence can also support selected HR activities, such as identifying recurring themes in employee feedback, recommending relevant training resources and assisting with routine HR queries.

However, technology should complement rather than replace meaningful human interaction. Sensitive employee concerns, workplace conflicts and career discussions often require empathy, judgement and personal attention.

HR departments must also ensure that employee data is handled securely and that engagement analytics are used transparently and responsibly.

Technology is most valuable when it reduces administrative friction, enables timely support and gives HR teams more time to focus on employee development and organisational culture.

11. Create Opportunities for Employee Participation and Innovation

Employees often have valuable insights into operational challenges, customer expectations and opportunities for improvement. Organisations can strengthen engagement by involving employees in decisions that affect their work.

HR teams and business leaders can introduce suggestion schemes, innovation challenges, employee committees, cross-functional projects and structured problem-solving sessions.

Employees should be encouraged to share ideas without fear of ridicule or unfair consequences. Managers should explain how suggestions are evaluated and recognise contributions that lead to meaningful improvements.

Participation can also extend to workplace policies, team processes and internal initiatives, provided the organisation establishes clear decision-making responsibilities.

Not every employee suggestion can be implemented. Nevertheless, transparent explanations and constructive discussions help maintain trust.

When employees have opportunities to influence outcomes, they can develop a stronger sense of ownership and become active contributors to organisational improvement.

12. Measure Employee Engagement Through Meaningful HR Metrics

Organisations need reliable indicators to evaluate whether their engagement strategies are producing results.

HR teams should establish a baseline, set measurable objectives and review progress at regular intervals. A combination of employee feedback and workforce performance data provides a more complete picture than any single metric.

Important indicators include:

  • Employee engagement scores: Measure employees’ reported commitment, motivation and connection to the organisation.

  • Employee turnover rate: Track the proportion of employees leaving during a defined period.

  • Employee retention rate: Assess the organisation’s ability to retain its workforce.

  • Absenteeism rate: Monitor absence patterns and investigate potential workplace issues.

  • Internal promotion rate: Evaluate opportunities for career progression and talent development.

  • Training participation: Assess access to and participation in learning initiatives.

  • Employee Net Promoter Score (eNPS): Measure employees’ willingness to recommend their organisation as a place to work.

  • Manager effectiveness scores: Assess employees’ perceptions of leadership support and communication.

  • Productivity and quality indicators: Examine whether workforce initiatives correspond with improvements in relevant operational outcomes.

These measures should be interpreted carefully. For example, a high eNPS does not automatically prove that employees are engaged, and low turnover may reflect limited external opportunities rather than strong workplace satisfaction.

HR teams should analyse trends across departments, roles and employee groups while protecting individual privacy. Combining quantitative data with interviews and open-ended feedback helps identify the reasons behind the numbers.

13. Develop a Structured Employee Engagement Action Plan

Employee engagement requires consistent implementation rather than isolated initiatives. HR departments can begin with a practical action plan that identifies priorities, responsibilities and measurable outcomes.

A structured approach may include the following stages:

Stage 1: Assess the current situation. Conduct an employee engagement survey, review turnover data and identify major workplace concerns.

Stage 2: Identify priority areas. Select the most significant issues, such as management communication, workload, recognition or career development.

Stage 3: Define measurable objectives. Establish realistic targets for engagement scores, employee retention, training participation or other relevant indicators.

Stage 4: Assign ownership. Identify the HR leaders, department heads and managers responsible for implementing each initiative.

Stage 5: Launch targeted initiatives. Introduce specific interventions based on employee feedback rather than applying identical solutions across every department.

Stage 6: Monitor progress. Review key indicators, gather employee feedback and assess whether the interventions are working.

Stage 7: Refine the strategy. Adjust programmes based on results, changing business needs and employee expectations.

This process enables HR departments to focus resources on the initiatives most likely to address organisational challenges.

Challenges in Implementing Employee Engagement Strategies

Despite the benefits, organisations may encounter several obstacles when implementing employee engagement initiatives.

Limited budgets can restrict access to training, wellness programmes and technology. Resistance to change may arise when managers are accustomed to traditional leadership practices. Employees may also hesitate to provide honest feedback if they fear negative consequences.

Another challenge is treating engagement as an HR responsibility alone. HR departments can design programmes and provide guidance, but business leaders and line managers must create the conditions that allow employees to thrive.

Organisations should avoid introducing too many initiatives simultaneously. A large number of disconnected activities can create administrative pressure without addressing the underlying causes of disengagement.

The most effective approach is to identify a small number of high-impact priorities, involve employees in designing solutions and demonstrate visible progress over time.

Conclusion

Employee engagement is a strategic business priority that influences workforce stability, organisational culture and the ability to achieve long-term objectives. Effective HR strategies must go beyond occasional rewards and team-building activities to address the everyday experiences that shape employees’ attitudes towards their work.

Transparent communication, meaningful recognition, career development, workplace flexibility, supportive leadership, employee well-being and continuous feedback form the foundation of a strong engagement framework.

Technology and HR analytics can strengthen these efforts by improving access to services and helping organisations identify workforce trends. However, lasting engagement ultimately depends on trust, fairness, respect and consistent management behaviour.

Businesses that treat employees as active contributors to organisational success are better positioned to develop a motivated and adaptable workforce. By measuring outcomes, listening to employee concerns and continuously refining their practices, HR teams can build workplaces where people feel valued, perform effectively and see a future for themselves within the organisation.

IndianOil Chairman A S Sahney delivers IIM Bangalore’s 53rd Foundation Day lecture on India’s energy journey

In his Foundation Day lecture at IIMB on ‘India’s Energy Journey’, IndianOil Chairman highlights that people are the backbone of successful organizations and that strong institutions boost a country’s success

29 October, 2026, Bengaluru: “India’s journey towards Viksit Bharat will depend on the collective strength of its institutions – industry, infrastructure, research, academia and young innovators – working together to build new capabilities and shaping a more resilient future. And as you step out of this remarkable institution, remember that strong foundations help withstand storms and give people the confidence to dream bigger – and the courage to achieve what once seemed impossible. So, build teams that believe in one another and never allow today’s limitations to define tomorrow’s achievements”, urged Shri A S Sahney, Chairman, IndianOil, while delivering the Foundation Day lecture on, ‘India’s Energy Journey: IndianOil’s Role in Securing Energy, Navigating Geopolitics and Building Resilience’, during IIM Bangalore’s 53rd Foundation Day celebrations, earlier today. The entire IIMB community – comprising students, faculty, former faculty, alumni and staff – were part of the event which included speeches, awards, and much more.

IndianOil Chairman A S Sahney delivers IIM Bangalore's 53rd Foundation Day lecture on India's energy journey

 

Purpose, resilience, trust, investing in future and transformation: Elements holding organizations together

A firm believer in people-centric leadership, Shri Sahney cited the example of the spirit in India’s women’s hockey triumph this year in the Asian Games, which, after a wait of 44 years, brought home gold. “It is a matter of immense pride for us that half the players in this victorious Indian team are IndianOil employees. But the glory belongs entirely to these remarkable women – their determination, their teamwork and their refusal to give up.”

Having worked across five of IndianOil’s nine refineries, and with over three decades of experience in refining and petrochemicals, he shared that most of his learnings about business and management happened on the job, through experience, mistakes and the people he worked with. Drawing attention to the profound changes around us in current times, he added, “Today, technology and AI help us track energy movements, optimize operations and make decisions that were unimaginable before. But the fundamentals of what holds organizations together remain unchanged.”

Stating that purpose is always tested during an emergency, he spoke of the times when the world faced the Covid crisis, during which his team displayed extraordinary courage, commitment and service to the nation – when duty took precedence over personal comfort and safety. “The core purpose of IndianOil as an organization is compassion with a nation-first attitude. And during the devastating second wave, IndianOil stepped forward to help meet the nation’s desperate need for the life-saving Liquid Medical Oxygen – supporting its production, procurement and transportation. That experience taught me that an institution’s strength lies not merely in its assets or technology, but in its people. To the future leaders here, your defining moments will come when circumstances are difficult, information is incomplete and others look to you for direction. Purpose is not what you say in good times, but what you do in bad times.”

Pointing out that in the current geopolitical scenario, building resilience will be the key, he added, “In an interconnected world, economic dependence itself can become an instrument of geopolitical power. For India, the answer is diversification, indigenous capability and strategic resilience, the ingredients of a well-functioning supply chain, especially when lives, livelihoods and national defence are concerned. During the recent LPG disruption, there was a very well-coordinated response from all our stakeholders to mitigate the crisis – from refinery engineers, procurement teams, railway personnel, truck drivers and distributors alike. IndianOil has effective policies to handle chokepoints, which have always received vital support from the government. Remember, we can model risks, but cannot always anticipate the next disruption. As future managers, you will repeatedly face a trade-off – between optimizing costs today and preparing for disruptions tomorrow. Just-in-time is efficient; but just-in-case is resilient.”

He also stressed on the importance of building resilient institutions through trust. “Employees must be granted the freedom to take decisions, challenge established practices, experiment and, occasionally, get things wrong. Leadership is not simply about getting the best out of people, but helping people discover the best within themselves. When people feel trusted, they move from compliance to commitment. A great institution’s contribution is measured not only by the business it builds, but also by the leaders it gives to the nation. As you make your career choices, look beyond the conventional paths; consulting, finance and technology offer exciting opportunities, but some of India’s greatest challenges and opportunities lie in energy, infrastructure, manufacturing, agriculture and the institutions that power our economy. Remember, targets may be achieved in a quarter; but the teams you build can shape an institution for generations.” Terming leadership development an institutional priority for IndianOil, he shared details about the company’s ‘Leaders of Tomorrow’ programme, which aims to groom promising executives for senior leadership roles.

His next advice to the students community was about investing in the future when the future itself is uncertain. “Preparation for facing the unimaginable is crucial. Our own investments are now progressively bearing fruit, reinforcing our belief in an energy future where conventional and emerging sources grow together. The essence of institution-building and nation-building lies in making decisions whose benefits extend far beyond our own tenure. Such investments also strengthen Atmanirbharta – building indigenous capabilities, creating opportunities for import substitution and reducing dependence on external supply chains. Commercial success and national responsibility can, and must, reinforce each other. And for the young managers here, there is a personal lesson as well. Invest in yourself before the rewards are visible. Take difficult assignments, learn unfamiliar skills and step beyond your comfort zone.”

He cautioned the young students against becoming prisoners of their own successes. “History tells us that no competitive advantage lasts forever. The very capabilities that made an organization successful can eventually become barriers to change. The best time to transform is when you are doing well, not when circumstances force you to. For those of you who will lead organizations tomorrow, remember that transformation does not always require dramatic restructuring or breakthrough technology. Longevity is not about preserving yesterday’s success, it is about remaining relevant tomorrow. Do not let the definition of your success become your prison; do not allow your degree, your first job or your early success to define your future. The greatest risk is not that the world will change, it is that we will fail to change with it. IndianOil’s own journey, its ability to adapt and remain relevant through changing times, reinforces this. Today, it is not merely an oil company, but an energy company. Your industry is not your identity. Your capabilities are.”

In this context, he discussed Project SPRINT launched by Indian Oil, which is a three-year transformation roadmap anchored in the 3Cs: Core, Cost and Customer and the 3Ts: Technology, Talent and Transition. “The 3Cs strengthen today’s business; while the 3Ts prepare it for tomorrow. We also sought to institutionalize SMART goals, translating strategic priorities into measurable commitments and clear accountability. The important outcome of the project was beginning to change how we think and work”, he explained. Shri Sahney champions operational excellence, cost consciousness, customer-centricity, innovation and talent development. Under his leadership, IndianOil is pursuing Project SPRINT, a company-wide transformation initiative to build a more agile, competitive and future-ready organization. Moreover, under his leadership, IndianOil is also accelerating its energy transition journey, with a strong thrust on biofuels, Compressed BioGas (CBG), Green Hydrogen and Sustainable Aviation Fuel (SAF).

Address by the Director In-charge

Prof. U Dinesh Kumar, Director-in-charge, IIM Bangalore, during his address, acknowledged and expressed gratitude for the support that the Institute continues to receive for all its activities and initiatives from the Central Government, particularly the Ministry of Education, and the Government of Karnataka, which includes the IIMBx FinTech Certificate Programme for Young Professionals. “Our collaboration with the Ministry of Minority Affairs as well as the National Minorities Development and Finance Corporation, Govt. of India, reflects our commitment to applying our expertise in public policy, entrepreneurship and innovation to create inclusive and sustainable economic opportunities, across the nation.”

Discussing IIMB’s newly-launched undergraduate programmes at the Jigani campus, he said, “The Tata Trusts have been instrumental in establishing the IIMB-Dorabji Tata School of Undergraduate Studies, while Axis Bank, with a generous contribution, has established a Centre of Excellence in Economics in our UG School and supports faculty development, research and student scholarships.”

IndianOil Chairman A S Sahney delivers IIM Bangalore's 53rd Foundation Day lecture on India's energy journey

 

Talking about IIMB’s valuable partnerships, he said, “Our incubation centre, NSRCEL, has also signed an MoU with IIT Kanpur to accelerate deep-tech start-ups and help translate emerging technologies into market-ready ventures.”

He went on to highlight IIM Bangalore’s major accomplishments over the past year, including its brilliant rankings, pathbreaking sustainability initiatives, and more. He also made special mention of the Institute’s faculty, students and alumni for their commitment to academic excellence, impactful research and institutional development, and for carrying the IIM Bangalore legacy forward with their myriad achievements.

Prof. Dinesh Kumar observed that the Institute’s responsibility was not merely to sustain excellence, but to continually redefine it. “We must remain relevant in a changing world, deepen our contribution to business and public policy, advance knowledge through research, and prepare leaders who create lasting value for society. It is a privilege to be part of an institution whose ambitions extend beyond its own success – to the advancement of management education, the development of responsible leadership and the progress of our nation.” He also upheld the value of compassion as the most powerful resource in the world, during his address.

IndianOil Chairman A S Sahney delivers IIM Bangalore's 53rd Foundation Day lecture on India's energy journey

 

Address by M. D. Ranganath, Member, BoG, IIM Bangalore

During his address, M. D. Ranganath, Member, Board of Governors, IIM Bangalore, underlined how IIMB has grown from strength to strength in the past 50 years. “Starting with one postgraduate programme, the Institute has scaled immensely and can now boast of UG programmes, digital programmes, executive programmes and more – leveraging technology and reaching the masses, partnering with government and corporate organizations, and scoring high in reputed national and global rankings. All this has been made possible due to the dedicated staff, faculty and students of the Institute, and I am sure the next half century will see IIMB reach even greater heights.”

Alumni Service Awards

The annual Alumni Service Awards (ASA) was launched in 2023 as part of the Golden Jubilee celebrations, to honor past graduates who have made impactful and enduring contributions to the Institute, the IIM Bangalore Alumni Association (IIMBAA) and the broader alumni ecosystem. Each recipient receives a citation in recognition of their service and commitment. This year, the recipients of the IIM Bangalore Alumni Service Awards were felicitated on the 53rd Foundation Day of IIMB. The recipients are Ganesan Ramachandran (PGP 1994) and Nityanand Shenoy (PGP 1987). Prof. Vasanthi Srinivasan, Dean, Alumni Relations & Development and faculty of the Organizational Behavior & Human Resources Management area, conducted the award ceremony and introduced the winners. “The alumni are the backbone of any institution, strengthening the institute as ambassadors and evangelists with their impactful and enduring contributions. IIMB’s ASA is an acknowledgement of their voluntary efforts”, Prof. Srinivasan declared. Utanka Sarma, Head – Alumni Relations and IIMBAA committee members were also present.

On winning the award, Ganesan said that IIM Bangalore has been an important part of his journey, and hailed the Institute for always offering high quality education and reinventing itself to stay ahead of the times. “Giving back to the institution and its alumni community is my way of expressing gratitude for all that it has given me”, he added.

Stating that IIM Bangalore has shaped his personal and professional journey, and that IIMBAA has enabled him to serve the Institute through its alumni community, Nityanand added, “I have always believed that the true value of an alumni network lies in staying connected and giving back. This is a commitment I have pursued sincerely and will continue to uphold.” He made special mention of the everlasting friendships he made during his tenure at IIMB.

Long Service Awards: For Faculty and Staff

This year, the Foundation Day celebrations also saw Long Service Awards being presented to non-teaching IIMB staff for completing 10 (thirteen employees), 15 (nine) and 35 (one) years of service at the Institute, as well as to faculty for having completed 10 (three awardees), 15 (one), 20 (six), 25 (one) and 30 (two) years of service.

The awards for staff were presented by Prof. Venkatesh Panchapagesan, Dean, Administration; Chairperson, Real Estate Research Initiative, and faculty of the Finance & Accounting area, and by Prof. Sourav Mukherji for faculty awardees.

Cdr Ajaya Kumar S, CAO, IIMB, who delivered the welcome address and the vote of thanks, anchored the different sessions.

 

VeriSilicon Introduces GLTiny™ 3D GPU Programming Model for Ultra-Low-Power, Memory-Efficient Wearable Devices

Optimized GLTiny Model Brings Rich 3D Graphics to Resource-Constrained Wearable Devices Powered by OpenGL ES GPUs

SHANGHAI, Oct. 29, 2026 /PRNewswire/ — VeriSilicon (688521.SH) announced GLTiny, an innovative 3D Graphics Processing Unit (GPU) programming model designed for wearable devices with stringent power and memory constraints. Featuring a streamlined Application Programming Interface (API) and an ultra-lightweight driver, GLTiny enables developers to leverage the 3D graphics capabilities of VeriSilicon’s Nano OpenGL ES GPU IP series for next-generation smartwatches, smart glasses, and other resource-constrained wearable devices.

Based on VeriSilicon’s extensive experience in wearable graphics applications, GLTiny incorporates configurable rendering functions that enable developers to easily define their rendering requirements while efficiently utilizing the underlying OpenGL ES GPU capabilities. This streamlined approach dramatically reduces driver memory footprint and CPU overhead, delivering improved power efficiency and optimized performance for resource-constrained wearable devices.

GLTiny provides native rendering support for standard glTF™ 3D models, allowing developers to directly import glTF content and render it through GLTiny APIs. It supports key features such as lighting models, skeletal skinning, and morph targets, as well as full glTF animation support, including flexible playback, switching between animation clips, and playback speed control. GLTiny also supports visual effects such as Gaussian blur and ripple effects, with simplified APIs designed to streamline 3D graphics development. In addition, GLTiny can be combined with VeriSilicon’s VGLite vector graphics driver to form an innovative hybrid driver, enabling coordinated rendering of 2.5D vector graphics and 3D models within the same frame.

“Power consumption and memory footprint are two of the most critical considerations in wearable devices, where delivering rich visual experiences within stringent resource constraints is essential,” said Weijin Dai, Chief Strategy Officer, Executive Vice President and General Manager of the IP Division at VeriSilicon. “Leveraging our extensive experience in wearable graphics and close collaboration with leading wearable SoC and device manufacturers, we developed GLTiny to address these challenges. Building on the success of VeriSilicon’s VGLite 2.5D GPU programming model, which has become a de facto industry standard for lightweight 2.5D graphics, GLTiny represents another important advancement in our graphics technology portfolio. Designed for seamless integration with the established wearable graphics content development ecosystem, GLTiny operates on VeriSilicon’s Nano OpenGL ES GPU IP series, enabling device manufacturers to deliver increasingly sophisticated visual experiences while meeting the stringent power and memory requirements of next-generation wearable devices.”

About VeriSilicon

VeriSilicon Microelectronics (Shanghai) Co., Ltd. (VeriSilicon, 688521.SH) is a leading publicly listed provider of custom silicon solutions, with a comprehensive and proprietary portfolio of semiconductor IPs, and a long-standing focus on AI ASIC custom silicon. For more information, please visit: www.verisilicon.com

Media Contact: press@verisilicon.com  

glTF™ is a trademark of The Khronos Group Inc.

Cision View original content:https://www.prnewswire.co.uk/news-releases/verisilicon-introduces-gltiny-3d-gpu-programming-model-for-ultra-low-power-memory-efficient-wearable-devices-302922093.html

VeriSilicon Introduces GLTiny™ 3D GPU Programming Model for Ultra-Low-Power, Memory-Efficient Wearable Devices

Casio to Release Lightweight Mechanical Watch with Excellent Readability

TOKYO, Oct. 29, 2026 /PRNewswire/ — Casio Computer Co., Ltd. announced the release of the CMK‑100, a lightweight mechanical timepiece with excellent readability. Combining comfort and practicality, the watch is suitable for a variety of occasions, from everyday use to business settings.

CMK-100TD-1A

The new CMK‑100, powered by an automatic movement, is designed for practicality in day-to-day life, with a lightweight construction and excellent readability. Developed in response to growing demand for mechanical watches, the watch is a handsome accompaniment to daily living.

The case is made with lightweight titanium, providing a comfortable fit even during extended wear. The case and bezel feature a hairline finish that gives the metal a refined appearance. A matte texture on the dial minimizes reflected light to ensure the time is easy to read. Raised indexes with multiple layers of phosphorescent paint create a strong contrast against the dial, ensuring excellent readability in the dark and in a wide range of other light conditions.

With 10-bar water resistance, the CMK‑100 is well suited for everyday use and outdoor activities alike. It is powered by a Made-in-Japan automatic movement.

Guided by the Casio Purpose — “Through the power to put wonder at hand, bring new levels of joy to lives one by one” — Casio has brought new value to the world in its timepiece business. Looking ahead, the company will continue to go beyond the practical function of timekeeping in watches, offering diverse functions and distinctive designs that deliver new joys of watch-wearing and thrills of discovery.

Model

Dial

Band

CMK‑100TD‑1A

Black

Titanium

CMK‑100TC‑1A

Black

Nylon

CMK‑100TCC‑8A

Gray

Nylon

CMK‑100TL‑1A

Black

Leather

CMK‑100TCL‑5A

Brown

Leather

 

CMK-100TD-1A/CMK-100TC-1A/CMK-100TCC-8A/CMK-100TL-1A/CMK-100TCL-5A

 

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/casio-to-release-lightweight-mechanical-watch-with-excellent-readability-302921631.html

Casio to Release Lightweight Mechanical Watch with Excellent Readability

KPM Analytics Introduces UCAL™ 5, a Guided NIR Calibration Platform for SpectraStar™ XT Analyzer Users

New NIR calibration platform for SpectraStar™ XT analyzers reviews every calibration against ASTM and ISO recommendations as the user works, builds a comparison calibration automatically, and teaches with built-in lessons. A 30-day free trial of UCAL 5 Pro is available today.

WESTBOROUGH, Mass., Oct. 28, 2026 /PRNewswire/ — KPM Analytics today announced UCAL 5, a near-infrared (NIR) calibration customization platform for SpectraStar XT Series analyzers. Its patent-pending guided workflow lets users start from KPM calibration libraries with spectra, add their own samples, and publish a calibration for their own products in four steps. As they work, UCAL Insight™ reviews the data, calibration, and validation results using recommendations from ASTM E1655 and ISO 12099 for developing and validating NIR calibrations. It highlights items the user may want to check before publishing the calibration.

UCAL 5 NIR Calibration Platform for SpectraStar XT Series Analyzers

UCAL 5 comes in three editions: Lite, currently included with new SpectraStar XT analyzers, which provides guided calibration development with the essential methods and tools; Pro for the analyst who builds and maintains calibrations; and Enterprise for teams that share projects on a company server.

A reviewer, a builder, and a coach inside the platform

In practice, a user imports spectra and laboratory values, builds the calibration in the Workbench, and sees UCAL Insight’s marks on the screen as each step is completed. With UCAL Autopilot switched on, the software builds its own calibration alongside the user’s from the same data, and the two appear side by side with the settings that differ. The lessons open from inside the software whenever they are needed.

UCAL Insight is the reviewer. At each step it checks whether there are enough samples, how well the laboratory values cover the required range, and whether new samples confirm the calibration. Each point is marked green, yellow, or red with an explanation of what it means and what to check. They are suggestions, not rules: the user always decides.

UCAL Autopilot™ is the builder. It tries several methods, presents the best, and lists every setting that differs from the user’s choices. After validation, the user compares the two calibrations property by property and decides which to publish.

Built-in lessons are the coach. Fifteen lessons inside the software explain what a calibration is, how it is judged, and why calibrations go wrong, then walk through the real UCAL 5 screens, from adding spectra to publishing a validated calibration. A separate introduction helps experienced UCAL 4 users move over. No previous calibration experience is needed.

“Most calibrations do not fail because the math is wrong. They fail because the samples did not cover the range, or because nobody checked the calibration against new samples before it went on the instrument,” said Yuegang Zhao, President of KPM Lab Solutions and Chief Commercial Officer at KPM Analytics. “UCAL 5 puts those checks in front of the user at every step, in the language of the standards the industry already trusts.”

Start from a proven KPM calibration

The KPM Analytics Web Store offers over 250 calibrations built and maintained by KPM’s application laboratories for food, feed, and agricultural products, from alfalfa hay and canola meal to cheddar cheese. They are sold by the property measured, such as moisture or protein, or in one of 15 ready-made bundles. A calibration is ready to use: it loads directly onto a SpectraStar XT analyzer, for one instrument or as a single file for a full fleet. Optionally, the same calibration can be bought as a calibration library with its spectra. The library opens in UCAL 5, where users add their own samples and keep the calibration current for their own products. The result is published as the user’s own calibration and loaded onto one analyzer or the whole fleet, like any KPM calibration.

“Our calibration library represents many years of application work with food, feed, and agricultural products,” said Zhao. “UCAL 5 is how a customer takes one of those calibrations and makes it their own.”

Four steps from data to a published calibration

UCAL 5 works in four steps: collect the data; clean the data and build the calibration in the Workbench; validate it against samples it has not seen; and combine and publish the final calibration. Every adjustment is saved apart from the original files, so any decision can be reversed. Users can try different settings on the same data, compare all results in one table, and publish the best result for each property as a single calibration file. Projects can be reopened and updated as crops, suppliers, and processes change. Through KPMLink® cloud-based management software, a finished calibration can be loaded onto every connected SpectraStar XT analyzer in the organization.

Editions for individual users and laboratory teams

UCAL 5 Lite provides guided calibration development: the lessons, UCAL Insight, UCAL Autopilot, and four calibration methods, with up to 500 samples per calibration from the user’s own files and no limit from KPM library files. It is currently included with new SpectraStar XT analyzers, available at an introductory price to other SpectraStar XT owners, and upgrades to Pro with a license key.

UCAL 5 Pro gives one analyst the full toolset: 18 calibration methods, including Modified PLS and three neural networks; advanced tools for sample selection and instrument standardization; and no limit on samples, so laboratories can build from years of historical data.

UCAL 5 Enterprise brings Pro to large teams. It installs on a company server, is used through a web browser, and is licensed per user, so data stays on the organization’s network. Each project can be private or shared.

UCAL 5 opens UCAL 4 files directly, and calibrations already on SpectraStar XT analyzers give the same results, so UCAL 4 users move their work without losing anything; they can upgrade to UCAL 5 Pro at a discount. Pro and Enterprise licenses include yearly maintenance for new versions. All editions are available in 11 languages.

Availability

A 30-day free trial of UCAL 5 Pro, Lite licenses, and calibrations are available today for current SpectraStar XT Series Analyzer users at https://store.kpmanalytics.com/join. Pro and Enterprise licenses are available now from KPM Analytics and its authorized distributors. See UCAL 5 in action at https://www.kpmanalytics.com/lp/ucal-5 or contact sales@kpmanalytics.com. 

About KPM Analytics

KPM Analytics is a global leader in scientific instrumentation, providing analytical and vision inspection solutions to laboratories and industrial operators in the food, feed, agriculture, industrial, and environmental sectors. KPM products have a long history of helping companies secure product quality, optimize production processes, and make confident, data-driven decisions through reliable solutions, supported by dedicated application expertise and local service. Visit https://www.kpmanalytics.com to learn more.

Media contacts:

Andy Dambeck

Product Marketing Manager

+1 774-399-0477

 

KPM Analytics

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kpm-analytics-introduces-ucal-5-a-guided-nir-calibration-platform-for-spectrastar-xt-analyzer-users-302920580.html

KPM Analytics Introduces UCAL™ 5, a Guided NIR Calibration Platform for SpectraStar™ XT Analyzer Users

Hexaware Reports Q3CY26 Revenue at USD 411.9 Mn, Up 4.3% YoY

 Q3CY26 Adjusted EBIT Margin at 13.8%, Increase of 17 bps QoQ

MUMBAI, India and ISELIN, N.J. and LONDON, Oct. 28, 2026 /PRNewswire/ — Hexaware Technologies (NSE: HEXT), a global provider of IT solutions and services, today announced financial results for the third quarter of calendar year 2026 ended Sep 30, 2026.

Hexaware's Office in Chennai

Financial Summary and Highlights


USD Mn


INR Mn

Q3CY26

QoQ (%)

YoY (%)


Q3CY26

QoQ (%)

YoY (%)

Revenue

411.9

1.6 %

4.3 %


39,331

2.3 %

12.9 %

EBIT

50.2

(9.3 %)

(13.5 %)


4,791

(8.5 %)

(6.5 %)

PAT

44.9

28.8 %

7.2 %


4,294

30.0 %

16.1 %

 

Constant Currency Growth

 

Q3CY26

QoQ %

YoY %

Revenue

1.7 %

4.5 %

 

Revenue:

  • Q3CY26: USD 411.9 Mn | INR 39,331 Mn
    • USD: +1.6% QoQ and +4.3% YoY | INR: +2.3% QoQ and +12.9% YoY
    • Constant Currency: +1.7% QoQ and +4.5% YoY

Profitability:

  • Adjusted EBIT (1):
    • Q3CY26: 13.8% | +17 bps QoQ and (88 bps) YoY in % terms
    • +2.9% QoQ and (1.9%) YoY in absolute terms
  • Basic EPS:
    • Q3CY26: INR 7.06 | +30.5% QoQ and 15.9% YoY

Key Client Metrics

  • Added one customer in the USD 20Mn+ category (LTM basis), increasing the total to 17 (from 16 in the previous quarter)
  • Top 10 customer revenue concentration at 35.4% in Q3CY26 (LTM basis)

Key People Metrics

  • Closing Headcount: 35,887, QoQ net addition of 1,381 with 386 net addition in IT
  • Voluntary Attrition for IT(2): 11.1%
  • Q3CY26 Utilization Rate for IT(3): 84.9%

Other Key Metrics

  • DSO (Billed + Unbilled) at 77 in Q3CY26, of which Billed is 41
  • LTM Q3CY26 Operating Cash Flow (OCF) to Reported Profit % at 109.6%
  • Cash and Cash Equivalents Position as of Sep 30, 2026, is USD 199 Mn(4) (5)

Leadership Speak

“I am delighted to join Hexaware at an exciting time for the company and our industry. What attracted me to Hexaware is its talented people, deep client relationships, and entrepreneurial culture. With AI creating new possibilities for enterprises across industries, I believe we have a tremendous opportunity to build on these strengths, deepen the impact we create for our clients, and shape the next phase of Hexaware’s growth.”

Vivek Jetley, CEO

“Q3 reflected continued progress across several key financial and operating metrics. Revenue grew sequentially, accompanied by a higher adjusted EBIT margin and strong cash conversion. Our focus now is to carry the momentum from our stronger businesses into broader growth while staying disciplined and investing in the capabilities that build lasting value.”

Vikash Jain, CFO

Financial Performance

Revenue Performance by Vertical

In USD Million

Q3CY26

QoQ

Q3CY26

YoY

Financial Services

3.0 %

2.4 %

Healthcare and Insurance

(0.4 %)

6.3 %

Manufacturing and Consumer

1.8 %

3.0 %

Professional Services

0.3 %

7.8 %

Banking

6.6 %

13.5 %

Travel and Transportation

(3.5 %)

(8.5 %)

Technology, Products & Platforms

7.2 %

9.7 %

Total Revenue

1.6 %

4.3 %

 

Revenue Performance by Geography

In USD Million

Q3CY26

QoQ

Q3CY26

YoY

Americas

1.5 %

1.1 %

Europe

3.1 %

12.8 %

Asia Pacific

(1.6 %)

20.0 %

Total Revenue

1.6 %

4.3 %

 

Key Wins

  • Selected by a smart home and property technology platform to deliver AI-native customer experiences
  • Partnered with a large US infrastructure provider for legacy modernization and an AI use case factory
  • Engaged by a leading Australian bank to enable data modernization
  • Engaged by a global pharmaceutical player for AI application and agentic development
  • Selected by a US biopharmaceutical company to lead its S/4HANA upgrade
  • Chosen by a Middle East-based bank to execute its Sitecore migration
  • Selected by a global data storage company to build end-to-end factory IT for its new production line
  • Chosen by a UK utility company to drive its modernization program

About Hexaware

We are a global digital and technology services company with artificial intelligence (“AI”) at our core. We leverage technology to deliver innovative solutions that help our customers in their digital transformation journey and subsequent operations. We embed AI into every aspect of our solutions and have created a suite of platforms and tools that allow our customers to adapt, innovate, and optimize in this AI-first era. We serve a diverse range of customers, including 30+ Fortune 500 organizations. With a team of 35,887 employees in 30+ countries, our presence is spread across major countries, nationalities, languages, time zones, and regulatory zones. For more information, please visit https://hexaware.com/.

Forward-looking Statements

Certain statements in this press release concerning our future growth prospects, litigations are forward-looking statements, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, intense competition in IT services including those factors which may affect our cost advantage, wage increases, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on work visa ,immigration, our ability to manage our international operations, the effect of current and any future tariffs, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, technological disruptions and innovations such as Generative AI ,our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies’ products and platforms in which Hexaware has made strategic investments, withdrawal of governmental fiscal incentives, political instability, legal restrictions on raising capital or acquiring companies, the outcome of pending litigation and unauthorized use of our intellectual property and general economic conditions affecting our industry. The Company may, from time to time, make additional written and oral forward statements. We do not undertake to update any forward statements that may be made from time to time by us or on our behalf unless required under the law.

Disclaimer

Use of Non-GAAP Financials

Hexaware has included certain non-GAAP financial measures in this Press release to supplement Hexaware’s consolidated financial statements presented on a GAAP basis. These non-GAAP financial measures may have limitations as analytical tools, and these measures should not be considered in isolation or as a substitute for analysis of Hexaware’s results as reported under GAAP. The non-GAAP financial information that we provide also may differ from the non-GAAP information provided by other companies. We compensate for the limitations on our use of these non-GAAP financial measures by relying primarily on our GAAP financial statements and using non-GAAP financial measures only supplementally. We believe that providing these non-GAAP financial measures in addition to the related GAAP measures provides investors with greater transparency. We further believe that providing this information better enables investors to understand Hexaware’s operating performance and financial condition

Rounding Off

Certain amounts and percentage figures included in this Press Release have been subject to rounding adjustments. Accordingly, figures shown as totals in certain tables may not be an arithmetic aggregation of the figures preceding them

Hexaware Logo

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/hexaware-reports-q3cy26-revenue-at-usd-411-9-mn-up-4-3-yoy-302922631.html

Hexaware Reports Q3CY26 Revenue at USD 411.9 Mn, Up 4.3% YoY